cephalosporin c has been researched along with Pancytopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Ponti, F; Gatti, M; Raschi, E | 1 |
| Berner, Y; Levi, S; Shahar, A | 1 |
2 other study(ies) available for cephalosporin c and Pancytopenia
| Article | Year |
|---|---|
Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporins; Drug Combinations; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Lactams; Male; Microbial Sensitivity Tests; Middle Aged; Pancytopenia; Pharmacovigilance; Retrospective Studies; Tazobactam | 2021 |
Fever, rash, and pancytopenia following vancomycin rechallenge in the presence of ceftazidime.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Hypersensitivity; Drug Interactions; Exanthema; Female; Fever; Humans; Pancytopenia; Vancomycin | 2000 |